SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Martek Biosciences---- future biotech cash cow!

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: nelli who wrote (61)6/12/1997 6:25:00 PM
From: nanoh   of 258
 
The Vector analist has not changed his numbers on MARTEK within last year and a half and the new estimates at least on revenue side are close to the numbers from Hambrecht. On the conference call the stated
that they are right on target as far as their buisness plan execution. They said that they had some problem with the new plant but that was fixed. They are expecting in the second half another partner to launch
full term. Today Hambrecht issued the report in which they said that the question is not if DHA will be included in formulas but really when. They think that MARTEK presents excellent value specially for longer term investors.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext